Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 5 | Breast Cancer Research

Figure 5

From: Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen

Figure 5

Low concentrations of endoxifen inhibit estrogen induced proliferation of MCF7-ERβ cells. Parental and MCF7-ERβ cells (cell lines #1 and #3) were treated as indicated for eight days and cell proliferation rates were analyzed. Graphs depict fold change from vehicle treated cells. * denotes significance at the P < 0.05 level (ANOVA) compared to vehicle controls, # compared to estrogen treated cells and δ for a given treatment between the two cell lines.

Back to article page